Tag: Heart disease treatment

Explore our medication guides and pharmacology articles within this category.

Mavacamten: What is the new drug for hypertrophic cardiomyopathy?

Oct 11, 2025 •

3 min read

Affecting approximately 1 in 500 people, hypertrophic cardiomyopathy (HCM) is a genetic heart condition that causes the heart muscle to thicken. Mavacamten (brand name Camzyos) is the new drug for hypertrophic cardiomyopathy, specifically for the obstructive type (oHCM).